Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network .

J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263.

PMID:
30103338
2.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ.

Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Erratum in: Lancet Neurol. 2017 Sep;16(9):683.

PMID:
28642124
3.

[Predictors of mental and physical quality of life in Huntington's disease].

Brugger F, Hepperger C, Hametner EM, Holl AK, Painold A, Schusterschitz C, Bonelli R, Holas C, Wenning GK, Poewe W, Seppi K.

Nervenarzt. 2015 Feb;86(2):167-73. doi: 10.1007/s00115-014-4187-3. German.

PMID:
25659843
4.

Suicidal ideation in a European Huntington's disease population.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington's Disease Network.

J Affect Disord. 2013 Oct;151(1):248-58. doi: 10.1016/j.jad.2013.06.001. Epub 2013 Jul 20.

5.

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.

Cubo E, González M, del Puerto I, de Yébenes JG, Arconada OF, Gabriel y Galán JM; European Huntington's Disease Initiative Study Group.

Mov Disord. 2012 Mar;27(3):439-42. doi: 10.1002/mds.24062. Epub 2011 Dec 9.

PMID:
22162184
6.

NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington's Disease Network, Arning L.

PLoS Curr. 2011 Oct 4;3:RRN1247. doi: 10.1371/currents.RRN1247.

7.

Discrepancies in reporting the CAG repeat lengths for Huntington's disease.

Quarrell OW, Handley O, O'Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer GB; European Huntington’s Disease Network.

Eur J Hum Genet. 2012 Jan;20(1):20-6. doi: 10.1038/ejhg.2011.136. Epub 2011 Aug 3.

8.

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Orth M; European Huntington's Disease Network, Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12. doi: 10.1136/jnnp.2010.209668. Epub 2010 Nov 19. No abstract available.

PMID:
21097549
9.

Weight loss in Huntington disease increases with higher CAG repeat number.

Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T; EHDI Study Group, Roos RA.

Neurology. 2008 Nov 4;71(19):1506-13. doi: 10.1212/01.wnl.0000334276.09729.0e.

PMID:
18981372
10.

Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.

Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Mariotti C, Lange HW, Weirich-Schwaiger H, Wenning GK, Seppi K, Melegh B, Havasi V, Balikó L, Wieczorek S, Zaremba J, Hoffman-Zacharska D, Sulek A, Basak AN, Soydan E, Zidovska J, Kebrdlova V, Pandolfo M, Ribaï P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O.

Hum Genet. 2006 Sep;120(2):285-92. Epub 2006 Jul 18.

PMID:
16847693
11.

Pharmacological management of Huntington's disease: an evidence-based review.

Bonelli RM, Wenning GK.

Curr Pharm Des. 2006;12(21):2701-20. Review.

PMID:
16842168
12.

Seminar on choreas.

Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W.

Lancet Neurol. 2006 Jul;5(7):589-602. Review.

PMID:
16781989
13.

Diffusion-weighted imaging in Huntington's disease.

Seppi K, Schocke MF, Mair KJ, Esterhammer R, Weirich-Schwaiger H, Utermann B, Egger K, Brenneis C, Granata R, Boesch S, Poewe W, Wenning GK.

Mov Disord. 2006 Jul;21(7):1043-7.

PMID:
16570300
14.

The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Soliveri P, Lange HW, Weirich-Schwaiger H, Wenning GK, Melegh B, Havasi V, Balikó L, Wieczorek S, Arning L, Zaremba J, Sulek A, Hoffman-Zacharska D, Basak AN, Ersoy N, Zidovska J, Kebrdlova V, Pandolfo M, Ribaï P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O.

Neurogenetics. 2006 Mar;7(1):27-30. Epub 2005 Dec 21.

PMID:
16369839
15.

Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.

Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.

Neuroimage. 2005 Feb 1;24(3):822-31. Epub 2004 Nov 24.

PMID:
15652317
16.

Huntington's disease: present treatments and future therapeutic modalities.

Bonelli RM, Wenning GK, Kapfhammer HP.

Int Clin Psychopharmacol. 2004 Mar;19(2):51-62. Review.

PMID:
15076012
17.

Trinucleotide repeat expansions in the junctophilin-3 gene are not found in Caucasian patients with a Huntington's disease-like phenotype.

Bauer I, Gencik M, Laccone F, Peters H, Weber BH, Feder EH, Weirich H, Morris-Rosendahl DJ, Rolfs A, Gencikova A, Bauer P, Wenning GK, Epplen JT, Holmes SE, Margolis RL, Ross CA, Riess O.

Ann Neurol. 2002 May;51(5):662. No abstract available.

PMID:
12112122
18.

Riluzole in Huntington's disease (HD): an open label study with one year follow up.

Seppi K, Mueller J, Bodner T, Brandauer E, Benke T, Weirich-Schwaiger H, Poewe W, Wenning GK.

J Neurol. 2001 Oct;248(10):866-9.

PMID:
11697523
19.

Intrafamilial heterogeneity of facial hyperkinesias: chance association of tics, cranial dystonia, and Huntington's disease?

Müller J, Wenning GK, Wissel J, Poewe W.

Mov Disord. 2001 Mar;16(2):370-2. No abstract available.

PMID:
11295801
20.

Neural transplantation in animal models of multiple system atrophy: a review.

Wenning GK, Granata R, Puschban Z, Scherfler C, Poewe W.

J Neural Transm Suppl. 1999;55:103-13. Review.

PMID:
10335497

Supplemental Content

Loading ...
Support Center